{"entity":{"type":"insider","cik":"0002066645","url":"/insider/0002066645","json_url":"/insider/0002066645.json","name":"Breedlove Robert Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2025-07-18","last":"2025-11-05","span_basis":"filed_date"},"name_variants":[{"name":"Breedlove Robert Charles","source":"filing","n_filings":3,"first_seen":"2025-07-18","last_seen":"2025-11-05"}],"transactions":[{"id":4271212,"accession":"0001193125-25-267057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-267057","line_url":"/filing/0001193125-25-267057#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0002066645","owner_name":"Breedlove Robert Charles","owner_display_name":"Breedlove Robert Charles","owner_url":"/insider/0002066645","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":524.0,"shares_display":"524","price_per_share":13.51,"price_display":"13.51","price_state":"stated","total_value":7079.24,"total_display":"7,079.24","total_whole":"7,079","shares_owned_after":47407.0,"shares_owned_after_display":"47,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider"},{"id":5119119,"accession":"0000950170-25-113822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113822","line_url":"/filing/0000950170-25-113822#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0002066645","owner_name":"Breedlove Robert Charles","owner_display_name":"Breedlove Robert Charles","owner_url":"/insider/0002066645","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":461.0,"shares_display":"461","price_per_share":12.09,"price_display":"12.09","price_state":"stated","total_value":5573.49,"total_display":"5,573.49","total_whole":"5,573","shares_owned_after":47931.0,"shares_owned_after_display":"47,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-09","scope":"insider"},{"id":4497103,"accession":"0000950170-25-096917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-096917","line_url":"/filing/0000950170-25-096917#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0002066645","owner_name":"Breedlove Robert Charles","owner_display_name":"Breedlove Robert Charles","owner_url":"/insider/0002066645","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1692.0,"shares_display":"1,692","price_per_share":8.3639,"price_display":"8.36","price_state":"stated","total_value":14151.7188,"total_display":"14,151.72","total_whole":"14,152","shares_owned_after":48392.0,"shares_owned_after_display":"48,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-07-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001783183","name":"Phathom Pharmaceuticals, Inc.","url":"/issuer/0001783183","role":"Officer (Principal Accounting Officer)","n_filings":3,"first_seen":"2025-07-18","last_seen":"2025-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002066645","retrieved_at":"2026-08-22T11:58:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}